Imperva, Inc.
NASDAQShare Statistics
Imperva, Inc. currently has 35.15M shares outstanding.
| Shares Outstanding | 35.15M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Imperva, Inc. trades at a trailing price-to-earnings ratio of 58.54. The price-to-sales ratio is 4.57, and the price-to-book ratio stands at -5.98.
| PE Ratio | 58.54 |
| PS Ratio | 4.57 |
| PB Ratio | -5.98 |
| P/TBV Ratio | 9.04 |
| P/FCF Ratio | 16.87 |
| P/OCF Ratio | 18.64 |
Financial Position
Imperva, Inc. maintains a current ratio of 2.04, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.04 |
| Quick Ratio | 1.95 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -5.02 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 217.22 |
Taxes
Over the trailing twelve months, Imperva, Inc. has paid 19.31M in income taxes, reflecting an effective tax rate of 29.47.
| Income Tax | 19.31M |
| Effective Tax Rate | 29.47 |
Stock Price Statistics
Imperva, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 55.67, while the 200-day moving average is 50.32.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 55.67 |
| 200-Day Moving Average | 50.32 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Imperva, Inc. generated 351.76M in revenue and converted that into -28.14M in net income, yielding earnings per share of -0.81. EBITDA reached 3.06M, while operating income came in at -9.76M.
| Revenue | 351.76M |
| Gross Profit | 279.64M |
| Operating Income | -9.76M |
| Pretax Income | -8.82M |
| Net Income | -28.14M |
| EBITDA | 3.06M |
| EBIT | -9.76M |
| Earnings Per Share (EPS) | -0.81 |
Balance Sheet
Total book value stands at -268.84M, with working capital of 197.89M providing operational flexibility.
| Cash & Cash Equivalents | 304.42M |
| Total Debt | N/A |
| Net Debt | -155.93M |
| Equity (Book Value) | -268.84M |
| Book Value Per Share | -7.77 |
| Working Capital | 197.89M |
Cash Flow
Imperva, Inc. produced 86.27M in operating cash flow over the past twelve months. After subtracting -9.81M in capital expenditures, free cash flow totaled 76.45M - equivalent to 2.21 per share.
| Operating Cash Flow | 86.27M |
| Capital Expenditures | -9.81M |
| Free Cash Flow | 76.45M |
| FCF Per Share | 2.21 |
Margins
Imperva, Inc. operates with a gross margin of 79.50, reflecting its pricing power and cost economics. The operating margin of -2.78 and net profit margin of -8.00 provide insight into operational efficiency.
| Gross Margin | 79.50 |
| Operating Margin | -2.78 |
| Pretax Margin | -2.51 |
| Profit Margin | -8.00 |
| EBITDA Margin | 0.87 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.28 |
| FCF Yield | 5.93 |
Scores
Imperva, Inc. posts an Altman Z-Score of 4.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.06 |